{"markup":"\u003C!DOCTYPE html PUBLIC \u0022-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\u0022 \u0022http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\u0022\u003E\n\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022 content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022 dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022 foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022 og=\u0022http:\/\/ogp.me\/ns#\u0022 rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022 sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022 sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022 skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022 xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022 mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\ngoogletag.slots[\u0022mpu\u0022] = googletag.defineSlot(\u0022\/21798771943\/JITC-MPU\u0022, [[300, 250], [300, 600], [300, 300], [600, 500]], \u0022dfp-ad-mpu\u0022)\n  .addService(googletag.pubads());\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/www.highwirestage.com\/sites\/default\/files\/js\/js_tC-Wb03AOcixlvV_-2WciA-geUEdV5eGfsQlr4DE1s4.js\u0022\u003E\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/d1bxh8uas1mnw7.cloudfront.net\/assets\/embed.js\u0022\u003E\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/www.highwirestage.com\/sites\/default\/files\/js\/js_U2pncm4Q4A7IJl4J_deoOoy8h9tU-3gxfOF4iwZdk_g.js\u0022\u003E\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/www.highwirestage.com\/sites\/default\/files\/js\/js_rvqD3pd7j-PZ6JZdAHt2fB3_x3qj-q5uJ__00yD2B_k.js\u0022\u003E\u003C\/script\u003E\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022panels_ajax_pane\u0022:{\u0022new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\u0022:\u0022{\\u0022encrypted\\u0022:\\u0022{\\\\\\u0022encrypted\\\\\\u0022:\\\\\\u0022+hqAp72OY8ewm+6qvvKrLwvsb+pNSs9Z5CUzIjWpqnr6Ox\\\\\\\\\\\\\\\/sX+i+0P6OnHpcq7+L9ohTdbvPWx5y\\\\\\\\\\\\\\\/eRit4RuyK\\\\\\\\\\\\\\\/Ejwp2atr7JIYfT2bA6GJ8uR9Mf\\\\\\\\\\\\\\\/KYafXhyMAtxn94V1qXZpgunJbHIJmrag7xBrt3G0Rvyab5wPfe9bmGnjIhcyHW9GkJVxDGTqPErleqpa91Llq+hzSLGlhQBrl2yeA3jyW6wt7wLmrco0Qblk8JdSffgaUDjSp83xllCey+H07bCh5iqu3B8X8o04lzFntV7PPoqHW440vk8kbUFXbf1OjJCGQKTB6HqeWcmR8JXoWLiAuiF6wxKfS602giRkxpUD9pZVocSFRfMFS3EM+8dcmca1yHL05QTsDT7V+RM6C0UNfmddehZu2bxTyGAdIpmxL0PuBq8YYif4BB7RluaDKUptcHVMkB3TZxKDrrGE8C7qZk+j+Ym3K9A7\\\\\\\\\\\\\\\/CCo3+ps9DPtbUGATp5IXWgqYfCrW\\\\\\\\\\\\\\\/A+2B76l+XvISXyRQhU8pebEs686QjKj4AYTkLaabXI3cyz\\\\\\\\\\\\\\\/tVhepHip3Huj5FykY0lujfXKOxttf+Rm5Q55esTCQLTDo0XpT7kcGL1f+hDhO\\\\\\\\\\\\\\\/7PulH62K1htGr8s5OsXB1TJ4EYjRgw8yFyvr0UrX24WysEeDbxOJB2qzRK3OV\\\\\\\\\\\\\\\/vcbuAA0ACKER2rlXwf8cAKonooGJbNs8q3TntRoobolw0loWJKoGsh1y9VMag3ijLIuxibGrpgPKMRk212Tz64PFfCT7SnrzF8emtc+2AXjcHL8dNUUeNJZ+ChPAc5HJT\\\\\\\\\\\\\\\/nz7j\\\\\\\\\\\\\\\/aJD5CcB7DR133jkhsWNak0bbTQ1GzWRdutVTRGQL4RQyi1XxbFQPQd71ejj6bIpuWjF0In8KKyZN7ifrGLR9u3w8h2V2lqfUD\\\\\\\\\\\\\\\/cmIGHYsQvzp3BVHYeCjCCzNL+fgbqUNKF3bNFT2QyeTPVRLkI8ovssizgsEQpOdY9DLNUjYg13vChls9RNHT6ggoGjR6EW+pYpR1gmtXN1ZRY9JAnLdd0OVCdO43c1oG2WBCdK1X20XuUB5vPiL4a5MyjPx2XdUHz9dcd0mUTwu7+2OPVDyqYsDrTCS70DCV5lWOLvw1vSPdpDz7rZ4CCks6rX\\\\\\\\\\\\\\\/428rnv\\\\\\\\\\\\\\\/aRFACZ3O68JPM\\\\\\\\\\\\\\\/fIg7ckIYxNBzYIoXg53pqjEnYDyEsO\\\\\\\\\\\\\\\/H6FwrYwBqqDWmHvYVUEZ1yysRPVUfVEmUu4ZDxASQoLo7ohzWjGWgtiKShq5Zc51KQkaB6qDdx58ywFka5uhjQfk1TkCutzfmVaC4v1BMEFqQ8s1dUPNzqcGTXUuBzYkKllyVm8aaHYBXmOcoFDFprkW6aWNmWfbJ2Hg\\\\\\\\\\\\\\\/3WjNQ5S2euS0luUbkaC3m7wwlFvB+t6B6EOleiG9vmc7aCU48J0lIWLyYadtZZXZMGIehOzn5zu+yrwVhNJ67Pcyxe5ruNEbDwAcgCtYJRAJHVuK6dcR6xT9AChfw5ZQC7t2X1gmwMQ84rPl5YRP9NDB8biqnHU8USOj8uE14XJtSVTJmoh9UDZ5pdj4EjnqYN62KJ7twdJepGZpp+qYksiCuV7R4FKrgFk5I2yGZig5COK4ay297MjngHPlux0Xb+CramfJuDb9X0L8d87agTM6sHCvjrC\\\\\\\\\\\\\\\/+YdNHKwsJSaTajbTrXdvQlwv9e6bvZxFMPp\\\\\\\\\\\\\\\/IwmhIG4pxZW4\\\\\\\\\\\\\\\/K1hmxlH786Ww9G1MYg4z1OZZQUIh9AV\\\\\\\\\\\\\\\/SDTCPw4UECNuXg9k519d7UFZsIuMbEZFfr884xI\\\\\\\\\\\\\\\/ua\\\\\\\\\\\\\\\/nWEKT373AspALnQSzGUwFSV4AErYZpELsACQXi7erXBCZSGO5+jxijisUBmm\\\\\\\\\\\\\\\/L7iGX3slb6uPgAhdUYbo4r9tdf5tst93NgIc7C+cM\\\\\\\\\\\\\\\/hPVkhj\\\\\\\\\\\\\\\/Qrl6CWkCQ0bThsTyEBAb42wwB7s+xXJkMXP1oW7Z\\\\\\\\\\\\\\\/WlcdFgmb7\\\\\\\\\\\\\\\/cWmGy\\\\\\\\\\\\\\\/ZbqAbEoGw4jl7WIJQjo6dg+xP+T\\\\\\\\\\\\\\\/nQ3ARUi6qnxXqB5tLCXTWQdl1KSUBcFiJ6SuZUEzhxZB0cOTGrcb7s1tGCqOM04pN\\\\\\\\\\\\\\\/5K7WTk9lhccfEd\\\\\\\\\\\\\\\/J40xS3IbZ8xpm3O\\\\\\\\\\\\\\\/1D7enJV+dgK4oMjdGyYvncqmYjCiEld3VBrEtf7m72pP65HMSW5EidMlWUsD+k1f\\\\\\\\\\\\\\\/JKvc6B3ipcbFHZwstddk7nb8oVOyXT6Ss3eHtYTc7darcAsPtREOpYFIxBZ4Vr0ELYIMznFnlDLRb1S0r99R6CcYQYtFg+HInJfSXNaXbqpvzjtcO5DdaLoQAu+Wz5LphfC+aVuXQ\\\\\\\\\\\\\\\/Be3w6aojaS2CUsNTVDjAmEQELw804GEzVOUSWzhl5s0gpuFRbwwiSjK040uDs4ToERmkSkQyKTXh9oOZnVaChLkHg89PvOztxtYSaoQaN67ZA2eshhrGpRLK1n6UKCJxvKJ4kDjxhGrjdnT\\\\\\\\\\\\\\\/ohitgi\\\\\\\\\\\\\\\/F+RjgD7PSPeTyQpbHaemPdnzhE6AK197GZZiQ4LSwlIkXSRUN1cDpYbG8uSfLQ8+OEibyb4FGY\\\\\\\\\\\\\\\/Q6EDvMpfbwm8fo9a3Y14fCYoy2ygiLZQPvlbDZPykzX\\\\\\\\\\\\\\\/vZCztoM072wBgZvNTmm9NWuxhet5Y\\\\\\\\\\\\\\\/eD8rX+dWuO6FIfGSL5mu+39gRBAA6DXchoDId+iMit6NA098qRlqI5vlgJUg=\\\\\\u0022,\\\\\\u0022iv\\\\\\u0022:\\\\\\u0022lG0X1JVej5NwDi5ElrsqgQ==\\\\\\u0022,\\\\\\u0022salt\\\\\\u0022:\\\\\\u00223fcf69c0544933648ca27e63b3137e55\\\\\\u0022}\\u0022,\\u0022hmac\\u0022:\\u0022a21173d64641c7da9da37864ad788a3265ae0639c39af24a7c81a1e97d08ff97\\u0022}\u0022},\u0022highwire\u0022:{\u0022ac\u0022:{\u0022\\\/jitc\\\/8\\\/1\\\/e000878corr1.atom\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022\u0022,\u0022apath\u0022:\u0022\\\/jitc\\\/8\\\/1\\\/e000878corr1.atom\u0022,\u0022jcode\u0022:\u0022jitc\u0022}},\u0022markup\u0022:[{\u0022requested\u0022:\u0022long\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022jitc;8\\\/1\\\/e000878corr1\u0022},{\u0022requested\u0022:\u0022abstract\u0022,\u0022variant\u0022:\u0022pdf-extract\u0022,\u0022view\u0022:null,\u0022pisa\u0022:\u0022jitc;8\\\/1\\\/e000878corr1\u0022},{\u0022requested\u0022:\u0022long\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022jitc;8\\\/1\\\/e000878corr1\u0022},{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022jitc;8\\\/1\\\/e000878corr1\u0022}],\u0022processed\u0022:[\u0022highwire_math\u0022]},\u0022MutationObserver\u0022:{\u0022js\u0022:\u0022\\\/sites\\\/all\\\/libraries\\\/mutationobserver\\\/MutationObserver.js\u0022},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u00221\u0022:1,\u0022sites\\\/default\\\/modules\\\/jnl_template_bmjj\\\/plugins\\\/highwire_markup_process\\\/js\\\/bmjj_author_affiliates.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/js\\\/highwire.javascript.pdf_extract.js\u0022:1,\u0022https:\\\/\\\/d1bxh8uas1mnw7.cloudfront.net\\\/assets\\\/embed.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/content_types\\\/js\\\/highwire_altmetrics.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/panels_ajax_pane\\\/panels_ajax_pane.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/www.highwirestage.com\/sites\/default\/files\/advagg_css\/css__WQiS3ck4zk_oYJMdLhTT-CHpv_wd1TntgyolXxchYqw__H8IDiO0U5hxt6_zxX1yD5dKF2jP5qm4oe8UqdAAcLMU__3qvfz4I9k5oUIeimOjbmdyh6ZgM-xweyVc5gub1_nR4.css\u0022 media=\u0022all\u0022\u003E\u003Clink rel=\u0022stylesheet\u0022 type=\u0022text\/css\u0022 href=\u0022\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0022\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-jnl-template-bmjj-tab-art\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022\u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup author-affiliates col-narrow-12 author-affiliates-corresp article\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 class=\u0022content-block-markup\u0022 xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup abstract-with-bc\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-custom pane-1\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cp\u003E\u003Ca href=\u0022https:\/\/doi.org\/10.1136\/jitc-2020-000878corr1\u0022 target=\u0022_new\u0022\u003Ehttps:\/\/doi.org\/10.1136\/jitc-2020-000878corr1\u003C\/a\u003E\u003C\/p\u003E\n  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-altmetrics\u0022\u003E\n  \n        \u003Ch2 class=\u0022pane-title\u0022\u003EStatistics from Altmetric.com\u003C\/h2\u003E\n    \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv data-badge-details=\u0022right\u0022 data-badge-type=\u0022medium-donut\u0022 data-doi=\u002210.1136\/jitc-2020-000878corr1\u0022 data-hide-no-mentions=\u0022true\u0022 class=\u0022altmetric-embed\u0022\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-custom pane-2 permissions-box\u0022\u003E\n  \n        \u003Ch2 class=\u0022pane-title\u0022\u003ERequest Permissions\u003C\/h2\u003E\n    \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cp\u003EIf you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center\u0026rsquo;s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.\u003C\/p\u003E\n  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-panels-ajax-pane-content permissions-box pane-highwire-permission-link\u0022 id=\u0022request-permissions\u0022\u003E\n  \n        \u003Ch2 class=\u0022pane-title\u0022\u003E\u003Cspan class=\u0022panels-ajax-pane-title\u0022 data-pid=\u0022new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\u0022\u003E\u003C\/span\u003E\u003C\/h2\u003E\n    \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022panels-ajax-pane panels-ajax-pane-new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\u0022 data-pid=\u0022new-70fd4c70-563e-4b94-ae3b-2a97f3980c13\u0022\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 class=\u0022content-block-markup\u0022 xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cp id=\u0022p-2\u0022\u003EAscierto PA, Fox B, Urba W, \u003Cem\u003Eet al\u003C\/em\u003E. Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. \u003Cem\u003EJ Immunother Cancer\u003C\/em\u003E. 2020;8:e000878. doi: 10.1136\/jitc-2020-000878\u003C\/p\u003E\u003Cp id=\u0022p-3\u0022\u003ESince the online publication of this article, the authors have noticed the following errors:\u003C\/p\u003E\u003Cp id=\u0022p-4\u0022\u003E1) The following authors were missing the middle initial in their name; Bernard A Fox, Walter J Urba, Julie R Brahmer, Daniel S Chen, Tanja D de Gruijl, F Stephen Hodi Jr, Howard L Kaufman, Michael T Lotze, Kim M Margolin, Francesco M Marincola. The author name Jon M Wigginton was also spelt incorrectly as Jon M Wiggington. The author list is shown below and has been updated in the article.\u003C\/p\u003E\u003Cp id=\u0022p-5\u0022\u003EPaolo Antonio Ascierto,\u003Csup\u003E1\u003C\/sup\u003E Bernard A Fox,\u003Csup\u003E2\u003C\/sup\u003E Walter J Urba,\u003Csup\u003E2\u003C\/sup\u003E Ana Carrizosa Anderson,\u003Csup\u003E3\u003C\/sup\u003E Michael B Atkins,\u003Csup\u003E4\u003C\/sup\u003E Ernest C Borden,\u003Csup\u003E5\u003C\/sup\u003E Julie R Brahmer,\u003Csup\u003E6\u003C\/sup\u003E Lisa H Butterfield,\u003Csup\u003E7\u003C\/sup\u003E Alessandra Cesano,\u003Csup\u003E8\u003C\/sup\u003E Daniel S Chen,\u003Csup\u003E9\u003C\/sup\u003E Tanja D de Gruijl,\u003Csup\u003E10\u003C\/sup\u003E Robert O Dillman,\u003Csup\u003E11\u003C\/sup\u003E Charles G Drake,\u003Csup\u003E12\u003C\/sup\u003E Leisha A Emens,\u003Csup\u003E13\u003C\/sup\u003E Thomas F Gajewski,\u003Csup\u003E14\u003C\/sup\u003E James L Gulley,\u003Csup\u003E15\u003C\/sup\u003E F Stephen Hodi Jr,\u003Csup\u003E16\u003C\/sup\u003E Patrick Hwu,\u003Csup\u003E17\u003C\/sup\u003E David Kaufman,\u003Csup\u003E18\u003C\/sup\u003E Howard L Kaufman,\u003Csup\u003E19\u003C\/sup\u003E Michael T Lotze,\u003Csup\u003E20\u003C\/sup\u003E Douglas G McNeel,\u003Csup\u003E21\u003C\/sup\u003E Kim A Margolin,\u003Csup\u003E22\u003C\/sup\u003E Francesco M Marincola,\u003Csup\u003E23\u003C\/sup\u003E Michael J Mastrangelo,\u003Csup\u003E24\u003C\/sup\u003E Marcela V Maus,\u003Csup\u003E25\u003C\/sup\u003E David R Parkinson,\u003Csup\u003E26\u003C\/sup\u003E Pedro J Romero,\u003Csup\u003E27\u003C\/sup\u003E Paul M Sondel,\u003Csup\u003E28\u003C\/sup\u003E Stefani Spranger,\u003Csup\u003E29\u003C\/sup\u003E Mario Sznol,\u003Csup\u003E30\u003C\/sup\u003E George J Weiner,\u003Csup\u003E31\u003C\/sup\u003E Jon M Wigginton,\u003Csup\u003E32\u003C\/sup\u003E Jeffrey S Weber\u003Csup\u003E33\u003C\/sup\u003E\u003C\/p\u003E\u003Cp id=\u0022p-6\u0022\u003E2) Affiliations 1, 2, 3, 4, 5, 11, 14, 15, 16, 20, 21, 22, 26, 28 were incorrect and affiliations 8, 32, 34 have been removed. The updated affiliation list is shown below and has been updated in the article.\u003C\/p\u003E\u003Cp id=\u0022p-7\u0022\u003E\n\u003Csup\u003E1\u003C\/sup\u003EIstituto Nazionale Tumori IRCCS Fondazione \u0027G. Pascale\u0027, Naples, Italy\u003C\/p\u003E\u003Cp id=\u0022p-8\u0022\u003E\n\u003Csup\u003E2\u003C\/sup\u003EEarle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA\u003C\/p\u003E\u003Cp id=\u0022p-9\u0022\u003E\n\u003Csup\u003E3\u003C\/sup\u003EHarvard Medical School, Boston, Massachusetts, USA\u003C\/p\u003E\u003Cp id=\u0022p-10\u0022\u003E\n\u003Csup\u003E4\u003C\/sup\u003EGeorgetown Lombardi Comprehensive Cancer Center, Washington DC, USA\u003C\/p\u003E\u003Cp id=\u0022p-11\u0022\u003E\n\u003Csup\u003E5\u003C\/sup\u003EUniversity of Wisconsin Clinical Cancer Center, Madison, Wisconsin, USA\u003C\/p\u003E\u003Cp id=\u0022p-12\u0022\u003E\n\u003Csup\u003E6\u003C\/sup\u003EJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA\u003C\/p\u003E\u003Cp id=\u0022p-13\u0022\u003E\n\u003Csup\u003E7\u003C\/sup\u003EResearch, Parker Institute for Cancer Immunotherapy, San Francisco, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-14\u0022\u003E\n\u003Csup\u003E8\u003C\/sup\u003EESSA Pharma Inc, Redwood City, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-15\u0022\u003E\n\u003Csup\u003E9\u003C\/sup\u003EIGM Biosciences Inc, Mountain View, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-16\u0022\u003E\n\u003Csup\u003E10\u003C\/sup\u003EMedical Oncology - Amsterdam University Medical Centers, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The Netherlands\u003C\/p\u003E\u003Cp id=\u0022p-17\u0022\u003E\n\u003Csup\u003E11\u003C\/sup\u003EAIVITA Biomedical, Inc, Irvine, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-18\u0022\u003E\n\u003Csup\u003E12\u003C\/sup\u003EHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA\u003C\/p\u003E\u003Cp id=\u0022p-19\u0022\u003E\n\u003Csup\u003E13\u003C\/sup\u003EUPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA\u003C\/p\u003E\u003Cp id=\u0022p-20\u0022\u003E\n\u003Csup\u003E14\u003C\/sup\u003EPathology and Medicine, Immunology and Cancer Program, University of Chicago, Chicago, Illinois, USA\u003C\/p\u003E\u003Cp id=\u0022p-21\u0022\u003E\n\u003Csup\u003E15\u003C\/sup\u003ENational Cancer Institute, Bethesda, Maryland, USA\u003C\/p\u003E\u003Cp id=\u0022p-22\u0022\u003E\n\u003Csup\u003E16\u003C\/sup\u003EDana Farber Cancer Institute, Boston, Massachusetts, USA\u003C\/p\u003E\u003Cp id=\u0022p-23\u0022\u003E\n\u003Csup\u003E17\u003C\/sup\u003EUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USA\u003C\/p\u003E\u003Cp id=\u0022p-24\u0022\u003E\n\u003Csup\u003E18\u003C\/sup\u003EBill \u0026amp; Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA\u003C\/p\u003E\u003Cp id=\u0022p-25\u0022\u003E\n\u003Csup\u003E19\u003C\/sup\u003EImmuneering Corp New York, New York, New York, USA\u003C\/p\u003E\u003Cp id=\u0022p-26\u0022\u003E\n\u003Csup\u003E20\u003C\/sup\u003EUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA\u003C\/p\u003E\u003Cp id=\u0022p-27\u0022\u003E\n\u003Csup\u003E21\u003C\/sup\u003ECarbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA\u003C\/p\u003E\u003Cp id=\u0022p-28\u0022\u003E\n\u003Csup\u003E22\u003C\/sup\u003EMedical Oncology, City of Hope National Medical Center, Duarte, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-29\u0022\u003E\n\u003Csup\u003E23\u003C\/sup\u003ERefuge Biotechnologies, Menlo Park, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-30\u0022\u003E\n\u003Csup\u003E24\u003C\/sup\u003EThomas Jefferson Medical College, Philadelphia, Pennsylvania, USA\u003C\/p\u003E\u003Cp id=\u0022p-31\u0022\u003E\n\u003Csup\u003E25\u003C\/sup\u003EMassachusetts General Hospital Cancer Center, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA\u003C\/p\u003E\u003Cp id=\u0022p-32\u0022\u003E\n\u003Csup\u003E26\u003C\/sup\u003EESSA Pharma Inc, Palo Alto, California, USA\u003C\/p\u003E\u003Cp id=\u0022p-33\u0022\u003E\n\u003Csup\u003E27\u003C\/sup\u003EOncology, University of Lausanne, Lausanne, VD, Switzerland\u003C\/p\u003E\u003Cp id=\u0022p-34\u0022\u003E\n\u003Csup\u003E28\u003C\/sup\u003EPediatrics, University of Wisconsin Madison, Madison, Wisconsin, USA\u003C\/p\u003E\u003Cp id=\u0022p-35\u0022\u003E\n\u003Csup\u003E29\u003C\/sup\u003EMassachusetts Institute of Technology Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts, USA\u003C\/p\u003E\u003Cp id=\u0022p-36\u0022\u003E\n\u003Csup\u003E30\u003C\/sup\u003EYale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA\u003C\/p\u003E\u003Cp id=\u0022p-37\u0022\u003E\n\u003Csup\u003E31\u003C\/sup\u003EHolden Comprehensive Cancer Center, The University of Iowa, Iowa City, Iowa, USA\u003C\/p\u003E\u003Cp id=\u0022p-38\u0022\u003E\n\u003Csup\u003E32\u003C\/sup\u003EMacroGenics Inc, Rockville, Maryland, USA\u003C\/p\u003E\u003Cp id=\u0022p-39\u0022\u003E\n\u003Csup\u003E33\u003C\/sup\u003ELaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Medical Center, New York, New York, USA\u003C\/p\u003E\u003Cp id=\u0022p-40\u0022\u003E3) In the main text,\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-1\u0022\u003E\u003Cli id=\u0022list-item-1\u0022\u003E\u003Cp id=\u0022p-41\u0022\u003EThe sentence \u0026acirc;\u0026#128;\u0026#152;The hypoxia and profound inflammatory response associated with the pneumonitis observed with the severe acute respiratory virus coronavirus-2 SARS-COV-2 virus\u0026acirc;\u0026#128;\u0026brvbar;\u0026acirc;\u0026#128;\u0026#153; now reads \u0026acirc;\u0026#128;\u0026#152;The hypoxia and profound inflammatory response associated with the pneumonitis observed with the SARS-CoV-2 virus\u0026acirc;\u0026#128;\u0026brvbar;\u0026acirc;\u0026#128;\u0026#153;\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-2\u0022\u003E\u003Cp id=\u0022p-42\u0022\u003EThe sentence \u0026acirc;\u0026#128;\u0026#152;One possibility is to encourage the use of IL-6 or IL-6-receptor (IL-6R) blocking antibodies like tocilizumab (Actemra, Roche-Genentech), sarilumab (Kevzara, Regeneron) and siltuximab (Sylvant, EUSA Pharma)\u0026acirc;\u0026#128;\u0026brvbar;\u0026acirc;\u0026#128;\u0026#153; now reads \u0026acirc;\u0026#128;\u0026#152;One possibility is to encourage the use of IL-6 or IL-6-receptor (IL-6R) blocking antibodies like tocilizumab (Actemra\u003Csup\u003ETM\u003C\/sup\u003E, Roche-Genentech), sarilumab (Kevzara\u003Csup\u003ETM\u003C\/sup\u003E, Regeneron) and siltuximab (Sylvant\u003Csup\u003ETM\u003C\/sup\u003E, EUSA Pharma)\u0026acirc;\u0026#128;\u0026brvbar;\u0026acirc;\u0026#128;\u0026#153;\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-3\u0022\u003E\u003Cp id=\u0022p-43\u0022\u003EThe sentence \u0026acirc;\u0026#128;\u0026#152;\u0026acirc;\u0026#128;\u0026brvbar;including tocilizumab and sarilumab for use on a compassionate basis to critically ill hospitalized COVID-19-infected patients during this extraordinary situation\u0026acirc;\u0026#128;\u0026#153; now reads \u0026acirc;\u0026#128;\u0026#152;\u0026acirc;\u0026#128;\u0026brvbar;including tocilizumab and sarilumab for use on a compassionate basis to critically ill hospitalized SARS-CoV-2-infected patients during this extraordinary situation\u0026acirc;\u0026#128;\u0026#153;\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cp id=\u0022p-44\u0022\u003E4) To acknowledge medical writing support, the acknowledgment section has been updated to read:\u003C\/p\u003E\u003Cp id=\u0022p-45\u0022\u003E\u0026acirc;\u0026#128;\u0026#152;The authors thank the clinicians working tirelessly on the frontlines of the COVID-19 pandemic. The authors also acknowledge SITC staff for their contributions including Sam Million Weaver, PhD for medical writing and editorial support and Angela Kilbert for project management and assistance. Additionally, the authors wish to thank the society for supporting the manuscript development.\u0026acirc;\u0026#128;\u0026#153;\u003C\/p\u003E\u003Cp id=\u0022p-46\u0022\u003E5) In the competing interests section:\u003C\/p\u003E\u003Cul class=\u0022list-unord \u0022 id=\u0022list-2\u0022\u003E\u003Cli id=\u0022list-item-4\u0022\u003E\u003Cp id=\u0022p-47\u0022\u003EBristol-Myers Squibb was spelt incorrectly as \u0026acirc;\u0026#128;\u0026#152;Bristol-Myer Squibb\u0026acirc;\u0026#128;\u0026#153; and \u0026acirc;\u0026#128;\u0026#152;Bristol-Myers-Squibb\u0026acirc;\u0026#128;\u0026#153;\u003C\/p\u003E\u003C\/li\u003E\u003Cli id=\u0022list-item-5\u0022\u003E\u003Cp id=\u0022p-48\u0022\u003EThe initials for authors BF, JB, ACA, DC, TdG. HK, ML, FM, KM now read BAF, JRB, AC, DSC, TDG, HLK, MTL, FMM, KAM\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup footnotes\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 class=\u0022content-block-markup\u0022 xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003Cdiv class=\u0022panel-separator\u0022\u003E\u003C\/div\u003E\u003Cdiv class=\u0022panel-pane pane-dfp-pane\u0022\u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv id=\u0022dfp-ad-mpu-wrapper\u0022 class=\u0022dfp-tag-wrapper\u0022\u003E\n\n\u003Cdiv id=\u0022dfp-ad-mpu\u0022 class=\u0022dfp-tag-wrapper\u0022\u003E\n  \u003Cscript type=\u0022text\/javascript\u0022\u003E\n    googletag.cmd.push(function() {\n      googletag.display(\u0022dfp-ad-mpu\u0022);\n    });\n  \u003C\/script\u003E\u003C\/div\u003E\n\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022http:\/\/www.highwirestage.com\/sites\/default\/files\/js\/js_am8GAfrhW3uXc7HVCmqF3MltMmNunvhyJ6MM_6EffRE.js\u0022\u003E\u003C\/script\u003E\u003C\/body\u003E\u003C\/html\u003E\n"}